The Andhra Pradesh chapter of the International Society for Pharmacoeconomics and Outcome Research (ISPOR) and the Raghavendra Institute of Pharmaceutical Education & Research (RIPER) are jointly organizing a national level seminar on Pragmatic View on Pharmacovigilance and Therapeutic Outcome at the Institute at Anandapur on May 5.

ISPOR promotes the science of pharmacoeconomics (health economics) and outcomes research, the scientific discipline that evaluates the effect of health care interventions on patient well-being. It includes clinical, economic, and patient-centred outcomes, and facilitates the translation of this research into useful information for health care decision makers to increase the efficiency, effectiveness, and fairness of health care to improve health. The society has over 7300 members in 105 countries.

Dr V Kalaiselvan, principal scientific officer for the Pharmacovigilance Programme of India (PvPI) at the Indian Pharmacopoeia Commission, will deliver the key note address. Ganesan Ramakrishnan, senior drug safety manager at Oviya Medsafe at Coimbatore will speak on Pharmacovigilance programme of India.

A panel discussion will be held in the afternoon session.